US Patent Issued to HDT Bio on Dec. 2 for "Cancer therapy compositions and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,163, issued on Dec. 2, was assigned to HDT Bio Corp. (Seattle).

"Cancer therapy compositions and uses thereof" was invented by Steven Gregory Reed (Bellevue, Wash.), Darrick Albert Carter (Seattle), Malcolm Scott Duthie (Sammamish, Wash.), Lars Peter Aksel Berglund (Seattle), Jesse Hong-Sae Erasmus (Port Orchard, Wash.) and Jiho Kim (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides compositions, methods of treatment, and methods of making and using compositions to deliver a nucleic acid to a subject. Compositions described herein include lipid carriers, optionally including an inorganic particle, capable of admixing with...